Viscoelastic agents
- PMID: 2655985
Viscoelastic agents
Abstract
Viscoelastic materials possess a unique set of properties that result from their chemical structure. These properties enable them to protect the corneal endothelium and epithelium from mechanical trauma and to maintain an intraocular space, such as the anterior or vitreous chambers, even in the face of an open incision. Hence viscoelastic materials have been successfully applied to many areas of ophthalmic surgery, most notably anterior segment surgery, with few complications. There are currently three commercially available viscoelastic preparations, and several new preparations are in various stages of development.
Similar articles
-
Corneal endothelial cell protection with a dispersive viscoelastic material and an irrigating solution during phacoemulsification: low-cost versus expensive combination.J Cataract Refract Surg. 2003 Apr;29(4):733-40. doi: 10.1016/s0886-3350(02)01745-5. J Cataract Refract Surg. 2003. PMID: 12686241 Clinical Trial.
-
Prospective comparison of the effects of Occucoat, Viscoat, and Healon on intraocular pressure and endothelial cell loss.J Cataract Refract Surg. 1991 Jan;17(1):21-6. doi: 10.1016/s0886-3350(13)80979-0. J Cataract Refract Surg. 1991. PMID: 2005554 Clinical Trial.
-
Viscoelastic substances in ophthalmology.Surv Ophthalmol. 1990 Jan-Feb;34(4):268-93. doi: 10.1016/0039-6257(90)90027-s. Surv Ophthalmol. 1990. PMID: 2111587 Review.
-
Evaluation of viscoelastic substances.J Cataract Refract Surg. 2001 Nov;27(11):1711-2. doi: 10.1016/s0886-3350(01)01203-2. J Cataract Refract Surg. 2001. PMID: 11709228 No abstract available.
-
Use of viscoelastic solutions in ophthalmology: a review of physical properties and long-term effects.J Long Term Eff Med Implants. 1992;2(1):49-66. J Long Term Eff Med Implants. 1992. PMID: 10149916 Review.
Cited by
-
Clinical observations of EVO-ICL implantation with single incision without viscoelastic agent.BMC Ophthalmol. 2024 Aug 14;24(1):344. doi: 10.1186/s12886-024-03587-3. BMC Ophthalmol. 2024. PMID: 39143510 Free PMC article.
-
Safety of EVO ICL Implantation With an Ophthalmic Viscosurgical Device-Free Technique in the Early 24 h After Surgery.Front Med (Lausanne). 2021 Nov 17;8:764653. doi: 10.3389/fmed.2021.764653. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34869472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources